加载中
NASDAQHealthcareMedical - Specialties
最新数据
US$11.9116
+US$0.0916 · +0.77%
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
常规交易时段
US$11.9265
+US$0.1065 · +0.90%
盘中时间采用ET。市场数据可能有所延迟。
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
日内区间
当前US$11.9265
52周区间
当前US$11.9265
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
53
合理估值
情绪
49
多空交织
风险
47
风险偏高
动量
55
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
日内区间
当前US$11.9265
52周区间
当前US$11.9265
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 5619.7万 USD | 5963.1万 USD | 5022.9万 USD | 4685.2万 USD | 4220.6万 USD |
| 销货成本 | 2940万 USD | 2970.6万 USD | 2490.7万 USD | 2082.9万 USD | 1897.3万 USD |
| 毛利 | 2679.7万 USD | 2992.5万 USD | 2532.2万 USD | 2602.3万 USD | 2323.3万 USD |
| 研究与开发 | 1380万 USD | 2549.5万 USD | 2190.4万 USD | 1752.6万 USD | 1306.7万 USD |
| 销售、一般及管理费用 | 3717.7万 USD | — | — | 4387.9万 USD | 3223.5万 USD |
| 营业费用 | 5097.7万 USD | 1.07亿 USD | 6808万 USD | 6140.5万 USD | 4530.2万 USD |
| 利息收入 | 413.6万 USD | 449.4万 USD | 648万 USD | 203.1万 USD | 54.8万 USD |
| 利息支出 | — | — | 20.1万 USD | 12.9万 USD | 48.6万 USD |
| 折旧和摊销 | 446.5万 USD | 468.2万 USD | 238.4万 USD | 161.4万 USD | 92.5万 USD |
| 营业利润 | −2418万 USD | −7671.8万 USD | −4275.8万 USD | −3538.2万 USD | −2206.9万 USD |
| 净利润 | −3663.9万 USD | −7220.6万 USD | −3639.9万 USD | −3356.3万 USD | −2216.9万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$12.00
上涨空间 0.62%报告持有此股票敞口的交易所交易基金。
ARK Genomic Revolution ETFARKG2321.87万1.13%22.19亿 USD0.75%US$48.79-1.39%
Avantis U.S. Small Cap Value ETFAVUV1175.92万0.04%309.17亿 USD0.25%US$120.09+0.13%
Vanguard Morningstar Total Stock Market ETFVTI981.46万0.00%2.3万亿 USD0.03%US$380.89-0.18%
iShares Russell 2000 ETFIWM945.85万0.01%787.4亿 USD0.19%US$276.37-0.55%
Vanguard Extended Market ETFVXF362.83万0.00%954亿 USD0.05%US$231.95-0.67%
iShares Russell 2000 Value ETFIWN342.97万0.02%137.49亿 USD0.24%US$210.5-0.28%
Schwab U.S. Small-Cap ETFSCHA206.62万0.01%217.13亿 USD0.03%US$32.495-0.51%
Vanguard Russell 2000 ETFVTWO178.06万0.01%180亿 USD0.06%US$111.63-0.57%ARK Genomic Revolution ETFARKGAvantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Value ETFIWNSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
